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Abnormal albuminuria and blood pressure rise in incipient diabetic
nephropathy induced by exercise. The aim of the study was to evaluate the
influence of light to moderate dynamic work (450 kpm/min followed by
600 kpm/min during 20 mm each) on the blood pressure and renal pro-
tein handling in insulin-dependent diabetic patients with incipient ne-
phropathy (D3) (elevated baseline albumin excretion but without clini-
cal proteinuria). Fifteen male diabetic patients (D3) with a mean age of
26.5 4.8 years (SD) and a diabetes duration of 15.6 3.4 years (SD),
II comparable diabetic patients with normal urinary albumin excretion
(D2), and ten non-diabetic subjects (C) were studied. In D3 baseline di-
astolic blood pressure was elevated [92.1 mm Hg 6.0 (mean SD)]
compared to D2 (80.9 mm Hg 4.8, 2P = 0.003%) and C (79.5 mm
Hg 12.4, 2P = 1.2%). Baseline systolic blood pressure was not sig-
nificantly different in the three groups, but systolic blood pressure was
more elevated at 600 kpm/min in D3 (193.0 mm Hg 23.0) compared
to D2 (170.5 17.3, 2P = 1.2%) and C (157.5 mm Hg 20.9, 2P =
0.07%). Baseline albumin excretion in D3 was 82.6 jg/min x/÷ 2.5
(geometric mean x I÷ tolerance factor) and during exercise the maxi-
mal albumin excretion rose to 195.0 tg/min x/± 2.6 (2P = 0.01%). In
D2 albumin excretion rose from 3.3 gImin xI÷ 1.9 to 7.9 g/min
xI÷ 1.5 (2P = 0.02%). The albumin excretion in C did not change
during exercise. A highly significant correlation between maximal ex-
ercise induced systolic blood pressure and maximal exercise induced
albumin excretion was demonstrable in D3. It is concluded that exer-
cise increases the already abnormal baseline albumin excretion and Un-
masks hyper-responsiveness in systolic blood pressure in patients with
incipient diabetic nephropathy.
Albuminurie induite par l'exercice et élévation de Ia pression artérielle
anormales lors de Ia néphropathie diabétique debutante produit par l'exer-
cice. Le but de cette étude a été d'évaluer l'influence d'un travail
dynamique faible ou modéré (450 kpni/min suivi par 600 kpnt/min pendant
20 mm chacun) sur Ia pression artérielle et l'excrétion rénale de protéines
chez des malades diabetiques insulino-indépendants atteints d'une nCph-
ropathie debutante (D3) (excretion d'albumine de base élevée, mais sans
protéinurie clinique). Quinze malades diabétiques masculins (D3) d'un
age moyen de 26,5 4,8 ans (SD) et d'une durée de diabéte de 15,6
3,4 ans (SD), 11 malades diabetiques comparables avec une excretion
urinaire d'albumine normale (D2), et dix sujets non diabétiques (C) ont
éte étudiés. Chez D3, Ia pression artérielle diastolique de base était
élevée (92,1 mm Hg 6, moyenne SD) par rapport a D2 (80,9 mm
Hg 4,8, 2P = 0,003%) et a C (79,5 mm Hg 12,4, 2 P = 1,2%).
La pression artérielle systolique de base n'était pas significativement
différente entre les trois groupes, mais Ia pression artérielle systolique
était plus élevée a 600 kpmlmin chez D3 (193,0mm Hg 23,0) par rap-
port a D2 (170,5 17,3, 2P = 1,2%) et C (157,5 mm Hg 20,9, 2P
= 0,07%). L'excrétion d'albumine de base chez D3 était de 82,6
.tg/min x I — 2,5 (moyenne géométrique >< / ÷ facteur de tolérence) et
pendant l'exercice l'excrétion maximale d'albumine s'est élevée a
195,0 g 1mm xI÷ 2,6 (2P = 0,01%). Chez D2 l'excrétion d'albumine
s'est élevée de 3,3 tg/min xI÷ 1,9 a 7,9 xI÷ 1,5 (2P = 0,02%).
L'excrétion d'albumine chez C n'a pas change pendant l'exercice. Une
correlation hautement significative entre Ia pression artérielle systol-
ique maximale induite par l'exercice et l'excrétion maximale
d'albumine induite par l'excercice était démontrable chez D3. On con-
clut que l'exercice augmente une excretion d'albumine de base déjà
anormale, et demasque une hyperstimulabilité de Ia pression artérielle
systolique chez des malades atteints de néphropathie diabetique
debutante.
The occurrence of proteinuria in a diabetic patient signals the
future decline in glomerular filtration rate (GFR), eventually
leading to uremia. In follow-up studies it has been demon-
strated that this 'nephropathic development' is found in about
30 to 50% of patients with juvenile onset diabetes, typically af-
ter a duration of diabetes of about 18 years in the mean [1, 21.
When decline in renal function begins, it seems to follow a
fairly linear course, not influenced by correction of metabolic
control [3] but ameliorated by antihypertensive treatment
which reduces the fall rate by 50 to 60% [4, 51.
If intervention in the future is to be more effective, it prob-
ably should be started earlier in the course of renal involve-
ment in the incipient phase of nephropathy characterized by
still supernormal GFR [6, 7] and permanently and significantly
increased albumin excretion, but not clinical proteinuria (> 0.5
g124 hr) in diabetic patients with about 8 or more years of dia-
betes. These changes in kidney function can only be detected
using sensitive methods, for example, radioimmunoassay [8,
9].
The aim of the present paper is to describe in these patients
the degree of renal involvement as well as the blood pressure
(BP) changes during one important daily life activity, physical
exercise, using a well defined test.
Methods
Fifteen young male diabetic patients with incipient ne-
phropathy (D3) were examined using the exercise test de-
scribed earlier [10]. The criterion for this definition is baseline
albumin excretion above 15 g/min (our upper normal limit)
and protein excretion below clinical proteinuria (0.5 g/24 hr)
and duration of diabetes of 8 years or more. Only patients be-
low the age of 40 years were examined. Such patients exhibit
normal serum creatinine and well-preserved kidney function
[7]. The patients were identified by screening in our out-pa-
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Table 1. Patients with incipient diabetic nephropathy (clinical data)
Later developed Actual
Pa- Diabetes Retinop-
overt diabetic
nephropathy Insulin
fasting
plasma
Mean previous
fasting plasma
Serum
creat-
Blood pressure
tient Age duration athy (proteinuria dose glucose glucose mg% mine Clinical Sys- Dia-
no. years years grade >0.5 g124 hr) JUl24 hr mg% (2 to 24 weeks) ing% proteinuria tolic stolic Mean
1 35 19 Simplex ÷,UA 84 168 105 0.8 Intermittent 130 93 105
2 24 12 Simplex + 60 109 166 0.8 None 115 80 92
3 22 13 Simplex ÷,U 60 176 203 1.0 None 120 89 99
4 22 12 Simplex ÷,IA 96 174 90 0.9 Intermittent 120 90 100
5 22 10 Simplex ÷,U 40 171 210 0.9 None 133 103 113
6 36 16 None ÷,IA 76 126 210 1.0 Intermittent 120 88 99
7 28 16 Simplex + 64 177 167 0.8 None 130 95 107
8 25 20 Simplex ÷,U 64 68 85 1.0 Intermittent 140 93 109
9 28 17 Simplex --,UA 56 133 105 0.8 Intermittent 125 85 98
10 20 15 Simplex + 72 160 217 0.8 Persistent
(0.5 g124 hr)
143 98 113
11 25 21 Simplex ? 40 187 64 0.9 Intermittent 133 88 103
12 33 21 Simplex + 44 140 126 0.8 Intermittent 150 97 115
13 25 13 Simplex ÷,IA 48 284 121 1.0 None 168 100 123
14 27 15 Simplex ÷,UA 64 129 III 0.9 Intermittent 130 92 105
15 26 14 Prolifera-
tions
+ 40 181 184 1.1 Persistent
(0.4 g124 hr)
125 90 102
Mean 26.5 15.6 60:5 158.9 144.3 0.9 132.1 92.1 105.5
SD 4.8 3.4 16.8 47.6 52.0 0.1 13.7 6.0 8.0
Abbreviations: U, unchanged elevated urinary albumin excretion rate micrograms per minute at least 1 year; I, increasing urinary albumin
excretion rate micrograms per minute; A, later on initiated antihypertensive treatment before fall in GFR.
tient clinic and during admission to the hospital, among pa-
tients without proteinuria (radioimmunoassay), with intermit-
tent or slight proteinuria (Albustix® and sulphosalicylic acid
method). Clinical data are shown in Table 1.
Eleven comparable male diabetic patients, aged 30.4 6.1
years (mean SD), with normal albumin excretion (D2) and a
diabetes duration of 14.8 4.6 years (mean SD) and ten
young healthy nondiabetic men aged 27.4 3.0 (SD) served as
control subjects. Definitions of stages in diabetic renal disease
(D1—D4) are given elsewhere [6, 7].
Diabetic patients and non-diabetic subjects were examined in
the morning in the fasting state; the diabetic patients received
their morning insulin after completing the test. Two pre-exer-
cise periods were included as well as three post-exercise pe-
riods, 20 mm at each period. Care was taken that urine output
was stable at the beginning of the pre-exercise baseline-period.
The patients drank water, 200 ml every 15 mm for 1.5 to 2 hr
or more prior to baseline periods. During the test they drank
200 ml every 20 mm. In this way temporary increase in albu-
min excretion due to excessive water loading is avoided [111.
The exercise loads were light to moderate first at 450 kpm/min
and then followed by 600 kpm/min, 20 mm at each load.
BP was measured auscultatorily employing a standard mer-
cury manometer with a 13.5 x 26cm hooklet cuff in the middle
of each period. Phase V was used for diastolic BP. Mean BP
was calculated from diastolic BP adding one third of the pulse
pressure to the diastolic BP. Only systolic values were taken
during exercise. Heart rate was recorded palpatory, measured
during 0.5 mm. Albumin and beta-2-microglobulin were meas-
ured by radioimmunoassay [12] (phadebase beta-2-microglobu-
lin-test®).
Statistics. Standard parametric methods were used to gather
data on albumin and beta-2-microglobulin excretion after loga-
rithm transformation.
Results
Baseline-data. By definition baseline albumin excretion was
considerably increased in D3: 82.6 g/min xl÷ 2.5 (geometric
means xI÷ tolerance factor) compared to the diabetic pa-
tients without nephropathy (D2) 3.3 tg/min x/± 1.9 (Fig. 1)
and the control subjects C 5.4 j.g/min x/÷ 1.6. Beta-2-micro-
globulin excretion in D3 was also elevated to a geometric mean
of 0.089 g/min x/÷ 1.6, versus 0.041 tg/min xl÷ 1.1 in D2
(2P = 0.04%) and 0.041 tg/min xl÷ 1.8 (2P = 0.3%) in C,
but to a much lesser extent. All values were within the gener-
ally accepted normal range [10]. There was no difference in the
beta-2-microglobulin excretion between D2 and C.
Both diastolic and mean BPs were significantly increased in
D3. Systolic BP in D3 was not significantly increased, but a ten-
dency was seen (Fig. 2). No difference in BP was seen be-
tween D2 and C.
No significant correlation to baseline albumin excretion was
demonstrable, neither to diastolic nor systolic pressures in D3,
D2, and C. The heart rate (beats/mm) was slightly but signifi-
cantly higher in D3 (69.4 8.8, mean SD) compared to D2
(60.4 6.3, mean SD, 2P = 0.8%) and nearly to C (6.24
7.6, mean sr, 2P = 5.1%).
Exercise-induced changes. There were significant increases
in both group D3 and D2 in albumin excretion at a workload of
600 kpm/min and a further increase at the first postexercise pe-
riod. Thereafter, the excretion rates regained the pre-exercise
levels. The relative increase in albumin excretion in percent
during exercise was equal in both D3 and D2 (Fig. I). In D3 a
few of the patients were unable to void after termination of ex-
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Fig. 1. Urinary albumin excretion (geometric mean x/÷ confidence
factor before, during, and after exercise in diabetic patients with
incipient diabetic nephropathy (D3) and comparable diabetic patients
with normal baseline albumin excretion (D2).
ercise (subjects 12, 13, 14, and 15) (Table 2). The albumin ex-
cretion was unchanged in the control subjects (C).
Beta-2-microglobulin excretion did not increase during ex-
ercise, indicating that the albumin increase is due to glomeru-
lar leakage.
An abnormal high systolic blood pressure (SBP) was noted
in the diabetic patients with incipient nephropathy compared to
D2 and C at 600 kpmImin. SBP was also abnormal in D3 at 450
kpm/min compared to control subjects (2P = 0.6%) (Table 3).
The increase in SBP was significantly higher in D3 compared
to control subjects both at 450 and 600 kpm/min. No signifi-
cant difference was seen in D2 compared to control subjects,
but we found a tendency (2P = 5.2% and 6.2% at 450 and 600
kpm/min, respectively) (Table 4). No significant differences
were seen between D3 and D2. The same tendency was seen
when the increase was expressed in percent increase but it was
only significantly different between D3 and C at 600 kpm/min
(2P 2.6%). During exercise there were no significant differ-
ences in the heart rate between the three groups.
Correlations between exercise induced changes. There was
a highly significant correlation between maximal exercise-in-
duced albumin excretion (mean of 600 kpm/min and first post-
exercise periods) and SBP at 600 kpm/min as shown in Figure
3. We found a significant correlation between total mean albu-
min excretion after exercise began (the two exercise and the
three post-exercise periods) and SBP at 600 kpm/min (r = 0.73,
N = 14, 2P = 0.3%).
Significant correlation was also found between maximal al-
bumin excretion (mean of 600 kpm/min and the first post-ex-
Table 2. Albumin excretion rate micrograms per minute before and
during exercises
Patient no. Baseline
Mean excretion
(2 exercise and 3
postexercise periods)
1 22.6 105.6
2 26.5 36.2
3 29.4 40.3
4 48.7 82.4
5 54.1 72.4
6 78.1 341.8
7 82.0 105.9
8 139.6 148.6
9 159.9 177.9
10 223.9 327.1
11 254.7 453.3
12 267.5 52l.5b
13 138.0 215.3c
14 187.7 354.7w
15 262.2 858.8c
Geometric mean 90.8 175.0
Tolerance factor 2.4 2.6
2 P = 0.02%
In the comparison of basal and exercise-induced albumin excretion,
the paired Student's t test and the derived P values are calculated after
log transformation.
b Urinary albumin excretion was not measured in the last two
postexercise periods.
The value shown was due to an absence of voiding between the
baseline period and the last postexercise period.
ercise periods) and baseline albumin excretion (Fig. 4). A sig-
nificant correlation was finally demonstrated between mean al-
bumin excretion in all periods after the start of exercise (two
exercise and the three post-exercise periods) and baseline al-
bumin excretion (r = 0.86, N = 14, 2P = 0.008%).
Discussion
This study demonstrates that light to moderate exercise in-
duces aggravation of already abnormal baseline albumin excre-
tion in incipient diabetic nephropathy. The observation agrees
with the study by Viberti et a! [13] and our own previous pa-
per, also on a very limited number of patients, as part of an-
other study [10]. The albumin excretion increased also in D2 as
shown earlier [10, 13]. The relative increase in albumin excre-
tion was the same in both D3 and D2 indicating that the law of
the initial values' also existed in this group of patients [14].
Also, we found that there was a highly significant correlation
between the basal and exercise-induced albumin excretion in
D3 indicating that the basal albumin excretion reflects what will
happen with the albumin excretion during exercise.
We also observed an abnormal exercise-induced SBP, not
demonstrable at rest, where diastolic and mean BPs were in-
creased. In his early studies, Karlefors [15] observed ab-
normal SBP during exercise in patients with long-term diabe-
tes, but he did not distinguish in his calculations between pa-
tients with and without nephropathy. Parving et a! [16] re-
cently found abnormal high basal BP in patients with persist-
ent proteinuria and normal serum creatinine. Despite a lower
albumin excretion in our study, baseline diastolic and mean BP
were also elevated compared to the two control groups (D2 and
C) as shown in Fig. 2.
1000
100
10
N = 12
2P 6.50% 0.70% 0.01% 2.60% NS
11
2P NS 0.63% 0.02% 5.10% NS
Baseline 450 600 1 2 3
132.L'
121 .0
Fig. 2. Baseline blood pressures in control
subjects (C), diabetic patients with normal
albumin excretion (D2) and diabetic patients
with incipient diabetic nephropathy (D3).
Exercise
Baseline 450 kpm/min 600 kpm/min N
C 121.0 14.9 147.5 18.0 157.5 20.9
D2 121.5 10.7 158.2 15.5 170.6 17.3
D3 132.1 13.7 172.9 21.7a 193.0 23.Ob.c
Abbreviations: C, controls (young healthy nondiabetic subjects); D2,
diabetic patients with normal albumin excretion; D3, diabetic patients
with incipient nephropathy.
2P = 0.6% (different from C).
b 2P = 0.07% (different from C).
2P = 1.2% (different from D2).
450 kpm/min 600 kpm/min
C 26.5 10.0 36.5 13.3
D2 36.6 13.0 49.1 14.5
D3 42.0 21.Sa 60.9 24.3b
It is important to note that exercise-induced albumin excre-
tion in D correlated well with the exercise-induced SBP level,
in contrast to diabetic patients with perfectly normal baseline
albumin values (D 2). In an earlier study in diabetic patients
with normal albumin excretion, a lack of correlation between
exercise-induced albumin excretion and maximal systolic BP
was also noted [10].
A high BP increase may well operate also during the daily
life situations of the patients and may be of importance for the
development of additional renal damage in the stage of incipi-
ent diabetic nephropathy. It is likely, since albumin excretion
rises, that pressure-increases are transmitted to glomeruli.
Therefore, evaluation of exercise-induced albuminuria and BP
increases would be of importance also during therapeutical tri-
als. In addition one would certainly hesitate to recommend
.5
0
is a
5)
10 5)5)
11
15
P
180 200 220 240 mm Hg
Systolic blood pressure, 600 kpm/min
Fig. 3. Maximal albumin excretion rate micrograms per minute (mean
of 600 kpm/min and first postexercise periods) plotted against maxi-
mal systolic blood pressure at 600 kpmlmin.
moderate and heavy physical exercise as adjunctive euglyce-
mic treatment of diabetes, when clinical nephropathy is
emerging.
Also, the significantly higher level in baseline diastolic and
mean BP in D3 does point to a possible adverse effect of in-
creased BP on renal function, The relative workload seems to
be in approximately of the same extent in all three groups,
since the heart rate responses were similar and no correlation
between albumin excretion and increases in heart rate was es-
tablished, suggesting that reduced physical fitness of the pa-
tients is not responsible for the abnormal albumin excretion
during exercise, which agrees with previous studies [10].
Abnormal exercise-induced albumin excretion is an early
feature in the renal involvement in diabetes. It is found at di-
agnosis but normalized after days to weeks of conventional in-
sulin treatment [17]. Thereafter, it reappears after some years
and the abnormality may be corrected by continuous subcuta-
neous insulin infusion, at least partially, as shown by Viberti
et a! [181 and Koivisto et a! [19].
It is concluded that the exercise test in patients with incipi-
ent diabetic nephropathy increases the already elevated albu-
min excretion and demasks hyper-responsiveness in SBP.
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E
E
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a
-o00
m
200
150
100
50
0
Mean
.i05.5'
NS 0.08%
0.8%
92.2J.
795.5. 80.9 ..
NS NS NS 0.003%
NS 1.2%
2P
C D2 D3 C D2 D3
Table 3. Systolic blood pressure, mm Hg (mean SD)
C D 03
1000
100
10
160
r 0.80N 12
2P 0.17%
Table 4. Increase in systolic blood pressure (mm Hg) during exercise
Abbreviations: C, control subjects; D2, diabetic patients with normal
albumin excretion; D3, incipient diabetic nephropathy.
a 2P = 4.6% (different from C).
b 2P = 0.8% (different from C).
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